Previous studies suggested that POLD1 proofreading domain mutations were identified as predisposing to a range of cancers, including colorectal cancer, endometrial cancer, skin squamous cell carcinoma, breast cancer, and brain tumor [6–8]. This evidence concerns the gene POLD1 and skin squamous cell carcinoma.